Company: DAWN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026654
Chunk: 286

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1B
Chunk 286
---
, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

/s/ Ernst & Young LLP

We served as the Company’s auditor from 2021 to 2023.

San Mateo, California

March 6, 2023

F-5

Day One Biopharmaceuticals, Inc.

Balance Sheets

(in thousands, except share and per share amounts)

    December 31,2024

    December 31,2023

    Assets

    Current assets:

    Cash and cash equivalents
     
    $
    124,968

    $
    230,784

    Short-term investments

    406,752

    135,563

    Accounts receivable, net

    13,876

    —

    Inventory

    3,321

    —

    Prepaid expenses and other current assets

    13,413

    8,927

    Total current assets

    562,330

    375,274

    Property and equipment, net

    2,285

    208

    Operating lease right-of-use asset

    2,422

    352

    Intangible assets, net

    15,630

    —

    Deposits and other long-term assets

    121

    214

    Total assets
     
    $
    582,788

    $
    376,048

    Liabilities and stockholders’ equity

    Current liabilities:

    Accounts payable
     
    $
    3,262

    $
    2,576

    Accrued expenses and other current liabilities

    68,625

    26,524

    Current portion of deferred revenue

    1,554

    —

    Current portion of operating lease liabilities

    10

    408

    Total current liabilities

    73,451

    29,508

    Long-term portion of deferred revenue

    3,233

    —

    Long-term portion of operating lease liabilities

    2,592

    —

    Other long-term liability

    761

    —

    Total liabilities

    80,037

    29,508

    Commitments and contingencies (